Stuart Nancy has filed 3 insider transactions across 1 company since September 2023.
Most recent transaction: a grant/award of 30000 shares of KalVista Pharmaceuticals, Inc. ($KALV) on October 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Stuart Nancy | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 53,883,681 | 9999.99% | 0.06% |
| Oct. 3, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Stuart Nancy | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 46,590,154 | 9999.99% | 0.02% |
| Sept. 26, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Stuart Nancy | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |